PRECIGEN, INC.
Develops gene and cell therapies for difficult-to-treat diseases using precision technology.
PGEN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US46122T1025 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 20374 SENECA MEADOWS PARKWAY, 20876 GERMANTOWN
- Website:
- https://precigen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Precigen, Inc. is a commercial-stage biopharmaceutical company focused on the discovery and development of next-generation gene and cell therapies. The company leverages precision technology and synthetic biology to create highly targeted medicines for difficult-to-treat diseases. Precigen's work spans from initial proof-of-concept and clinical trials through to commercialization, aiming to advance scientific breakthroughs into approved medical treatments. The company was formerly known as Intrexon Corporation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PRECIGEN, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PRECIGEN, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PRECIGEN, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
